CalPERS Commends GlaxoSmithKline's Move to Cut Price of AIDS Drugs

CalPERS Commends GlaxoSmithKline's Move to Cut Price of AIDS Drugs

Business Wire - April 28, 2003

SACRAMENTO, Calif.--Sean Harrigan, President of the California Public Employees' Retirement System's Board of Administration issued the following statement today about news that GlaxoSmithKline is cutting the price of its combination AIDS drug Combivir:

"Glaxo should be commended for this move. It is a significant step forward for the company. We asked the company to examine the price of their AIDS therapy drugs and offer the lowest possible price without long-term harm to the company. Glaxo has answered with good news that will help advance the HIV work in the world's poorest countries while considering the financial health of its shareholders."

"We recognize that Glaxo has an established and effective humanitarian programs. We urge them to continue to work with the AIDS community to further their efforts, and we look forward to a continued dialogue with the company about their work in this area."

CONTACT: CalPERS - Office of Public Affairs

Brad Pacheco, 916/326-3991

SOURCE: CalPERS

030428
BW030409

Copyright © 2003 - Business Wire. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the Business Wire, Permissions Desk, Business Wire, 1185 Avenue of the Americas, 3rd Floor, New York, NY 10036; Tel: (212) 575-8822; FAX: (212) 575-1854. http://www.businesswire.com.

AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, Elton John AIDS Foundation, iMetrikus, Inc., John M. Lloyd Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2003. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2003. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .